Sangamo Therapeutics
SGMO
#10631
Rank
ยฃ23.13 M
Marketcap
ยฃ0.05583
Share price
0.00%
Change (1 day)
-88.66%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ81.5 Million a decrease over its 2024 earnings that were of -ยฃ74.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million0.76%
2025 -ยฃ81.5 Million9.71%
2024 -ยฃ74.29 Million-17.27%
2023 -ยฃ89.79 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97.75 Million23.17%
2019 -ยฃ79.37 Million36.33%
2018 -ยฃ58.22 Million36.89%
2017 -ยฃ42.53 Million-22.32%
2016 -ยฃ54.75 Million54.86%
2015 -ยฃ35.36 Million75.62%
2014 -ยฃ20.14 Million0.13%
2013 -ยฃ20.11 Million
2011 -ยฃ27.03 Million43.66%
2010 -ยฃ18.82 Million28.52%
2009 -ยฃ14.64 Million-23.55%
2008 -ยฃ19.15 Million2.45%
2007 -ยฃ18.7 Million19.5%
2006 -ยฃ15.65 Million50.78%
2005 -ยฃ10.38 Million75%
2004 -ยฃ5.93 Million-33.25%
2003 -ยฃ8.88 Million-62.27%
2002 -ยฃ23.54 Million102.82%
2001 -ยฃ11.61 Million23.21%
2000 -ยฃ9.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.60 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.85 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.22 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.91 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ8.09 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.92 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.65 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.29 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA